Xconomy National

Archives

by in
Entry Author Date Location
OncoSec Medical Advancing Inovio’s Technology Against Cancer Bruce V. Bigelow 02/08/12 San Diego
Applied Proteomics, Co-Founded by Danny Hillis, Gets New CEO, $22.5M Bruce V. Bigelow 02/07/12 San Diego
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy Bruce V. Bigelow 02/03/12 San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News Erin Kutz 02/03/12 Boston
San Diego Life Sciences Strengthened in Recession, Outpacing Nation Bruce V. Bigelow 02/01/12 San Diego
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says Luke Timmerman 02/01/12 Boston
Avila, iRobot, Verastem, Illume, & More Boston Deal News Erin Kutz 02/01/12 Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug Luke Timmerman 01/31/12 Boston
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic Luke Timmerman 01/31/12 San Diego
Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel Luke Timmerman 01/30/12 Seattle
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug Luke Timmerman 01/27/12 National
Infinity Drug Fails in Pancreatic Cancer Trial, Shares Fall Luke Timmerman 01/27/12 Boston
OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation Luke Timmerman 01/27/12 Seattle
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers Erin Kutz 01/27/12 Boston
San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More Bruce V. Bigelow 01/26/12 San Diego
Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly Luke Timmerman 01/25/12 San Francisco
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race Luke Timmerman 01/24/12 Boston
Novo Nordisk Adds Diabetes Research to Seattle Immunology Team Luke Timmerman 01/23/12 Seattle
Millennium Wins FDA OK for New Velcade, Looks to Fend Off Onyx Luke Timmerman 01/23/12 Boston
Infinity Offers Hint Of Effect With Pancreatic Cancer Drug Luke Timmerman 01/20/12 Boston
Millennium, Looking to Fend Off Onyx, Awaits FDA Word on New Velcade Luke Timmerman 01/20/12 Boston
San Diego VC Activity at Ebb Tide in 2011 and Top 10 Local Deals Bruce V. Bigelow 01/20/12 San Diego
SD Life Sciences News: Auspex, BrainCells, and J&J’s Startup Center Bruce V. Bigelow 01/19/12 San Diego
Frazier Healthcare Aims for First Biotech VC Fund After Financial Crisis Luke Timmerman 01/19/12 Seattle
Global Healthcare Dennis Purcell 01/18/12 New York
Onyx, Bayer’s Next Cancer Drug Shows Slim Survival Edge Luke Timmerman 01/17/12 San Francisco
Medivation Fails Alzheimer’s Trial, Pfizer Drops Out of Partnership Luke Timmerman 01/17/12 San Francisco
Sanofi CEO Viehbacher on Stirring Innovation in the Era of R&D Cutbacks Luke Timmerman 01/17/12 National
Seattle Genetics Sees Updated Side Effect Warning in Drug Label Luke Timmerman 01/13/12 Seattle
The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More Erin Kutz 01/13/12 Boston
Page 1 of 52 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.